S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Attorney says West Virginia governor refusing to pay judgment in coal lawsuit
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Twitter executive responsible for content safety resigns after Elon Musk criticism
LON:MPH

Mereo BioPharma Group plc (MPH.L) (MPH) Share Forecast, Price & News

GBX 26.50
-0.50 (-1.85%)
(As of 12/17/2020)
Compare
Today's Range
26
26.50
50-Day Range
26.50
26.50
52-Week Range
13
60
Volume
49,264 shs
Average Volume
333,975 shs
Market Capitalization
£89.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MPH stock logo

About Mereo BioPharma Group plc (MPH.L) (LON:MPH) Stock

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company also develops Navicixizumab (OMP-305B83) that is in Phase 1a clinical trial for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that has completed Phase II clinical trial to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody, which is in Phase IIb clinical trial for the treatment of osteogenesis imperfect; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. Mereo BioPharma Group plc was founded in 2015 and is based in London, the United Kingdom.

Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mereo BioPharma Group plc (MPH.L) and its competitors with MarketBeat's FREE daily newsletter.

MPH Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Short Volatility Alert: Mereo Biopharma
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Why Mereo BioPharma Shares Are Jumping Today
Mereo BioPharma Group PLC ADR (MREO)
See More Headlines

MPH Price History

MPH Company Calendar

Last Earnings
9/29/2020
Today
6/03/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 17.12 per share
Book Value
GBX 7.20 per share

Miscellaneous

Free Float
N/A
Market Cap
£89.76 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Denise Scots-Knight (Age 61)
    Co-Founder, CEO & Exec. Director
    Comp: $751.37k
  • Mr. Charles Sermon (Age 51)
    Co-Founder, Gen. Counsel & Company Sec.
    Comp: $545.68k
  • Dr. Alastair MacKinnon (Age 50)
    Co-Founder & Chief Medical Officer
    Comp: $540.12k
  • Mr. John Richard (Age 63)
    Co-Founder & Head of Corp. Devel.
    Comp: $512.99k
  • Mr. Michael Stephen Wyzga MBA (Age 65)
    Interim CFO & Exec. Director
    Comp: $27.59k
  • Ms. Alexandra Hughes-Wilson (Age 49)
    Head of Patient Access & Commercial Planning
    Comp: $265.93k
  • Ms. Jill Henrich (Age 57)
    US Site Head & Sr. VP of Regulatory Affairs
    Comp: $286.93k
  • Dr. John A. Lewicki (Age 68)
    Chief Scientific Officer
  • Dr. Fiona Bor
    Head of Intellectual Property
  • Mr. Ian Hodgson
    Head of Clinical Operations













MPH Stock - Frequently Asked Questions

How have MPH shares performed in 2023?

Mereo BioPharma Group plc (MPH.L)'s stock was trading at GBX 26.50 on January 1st, 2023. Since then, MPH shares have increased by 0.0% and is now trading at GBX 26.50.
View the best growth stocks for 2023 here
.

How were Mereo BioPharma Group plc (MPH.L)'s earnings last quarter?

Mereo BioPharma Group plc (MPH.L) (LON:MPH) issued its quarterly earnings results on Tuesday, September, 29th. The company reported ($105.00) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Mereo BioPharma Group plc (MPH.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mereo BioPharma Group plc (MPH.L) investors own include Enanta Pharmaceuticals (ENTA), Advanced Micro Devices (AMD), American Tower (AMT), Inovio Pharmaceuticals (INO), Micron Technology (MU), Tesla (TSLA), Amgen (AMGN), ARMOUR Residential REIT (ARR), Arena Pharmaceuticals (ARNA) and Ardelyx (ARDX).

What is Mereo BioPharma Group plc (MPH.L)'s stock symbol?

Mereo BioPharma Group plc (MPH.L) trades on the London Stock Exchange (LON) under the ticker symbol "MPH."

How do I buy shares of Mereo BioPharma Group plc (MPH.L)?

Shares of MPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Mereo BioPharma Group plc (MPH.L)'s stock price today?

One share of MPH stock can currently be purchased for approximately GBX 26.50.

How much money does Mereo BioPharma Group plc (MPH.L) make?

Mereo BioPharma Group plc (MPH.L) (LON:MPH) has a market capitalization of £89.76 million.

How can I contact Mereo BioPharma Group plc (MPH.L)?

Mereo BioPharma Group plc (MPH.L)'s mailing address is 1 Cavendish Place, LONDON, W1G 0QF, United Kingdom. The official website for the company is mereobiopharma.com. The company can be reached via phone at 44 33 3023 7300.

This page (LON:MPH) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -